INMD (INMD) Stock Price & Analysis

INMD (INMD) rose 0.44% to USD 13.56 as of June 10, 2026 at 03:42 UTC, according to Nexqual real-time market data.

INMD last closed at USD 13.5; the session ranged USD 13.47–13.66 on volume of 484,624 shares. Market capitalization is $824.57M, with a 52-week range of USD 12.72–16.74 (NMS). Source: Nexqual, June 10, 2026 at 03:42 UTC.

Key Statistics (as of June 10, 2026 at 03:42 UTC)

PriceUSD 13.56
Change▲ 0.44% (up)
Previous CloseUSD 13.5
OpenUSD 13.53
Day RangeUSD 13.47 – 13.66
52-Week RangeUSD 12.72 – 16.74
Volume484,624 shares
Market Cap$824.57M
ExchangeNMS

Technical Analysis (INMD)

Nexqual's technical model rates INMD "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:42 UTC.

Overall SignalSTRONG SELL
RSI (14)40.53 (neutral)
vs SMA50Below (USD 13.95)
MACD-0.13 (negative)

Analyst Ratings (INMD)

Wall Street analysts rate INMD "Hold" based on 3 analysts, with a mean price target of USD 14.33 (range USD 14–15), per Nexqual as of June 10, 2026 at 03:42 UTC.

Consensus RatingHold
Analyst Count3
Mean TargetUSD 14.33
High TargetUSD 15
Low TargetUSD 14
Buy / Hold / Sell0 / 5 / 0

Earnings (INMD)

Next Earnings Date2026-07-30
EPS EstimateUSD 0.33
Revenue Estimate$92.65M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD 0.25 vs est 0.3 ▼ miss
2025-12-31USD 0.46 vs est 0.42 ▲ beat
2025-09-30USD 0.38 vs est 0.35 ▲ beat
2025-06-30USD 0.47 vs est 0.41 ▲ beat

Source: Nexqual, June 10, 2026 at 03:42 UTC.

Financials & Fundamentals (INMD)

Total Revenue$374.64M
Revenue Growth (YoY)+5.30%
Gross Margin+77.84%
Operating Margin+12.26%
Profit Margin+23.27%
ROE+13.62%
Debt / Equity0.73
Current Ratio8.8
Total Cash$537.16M
Total Debt$4.83M
Free Cash Flow$43.63M

Source: Nexqual, June 10, 2026 at 03:42 UTC.

Financial Health Score (INMD)

Nexqual rates INMD's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 03:42 UTC.

GrowthWeak — Revenue -6% YoY (annual), declining
ProfitabilityStrong — Gross margin 78%, operating 12%
Balance SheetStrong — $537M cash vs $5M debt, net cash position
Cash FlowSolid — FCF $44M, 12% margin
EfficiencyMixed — ROE 14%, ROA 6.9%

Ownership (INMD)

Insider Ownership+11.92%
Institutional Ownership+54.24%
Shares Outstanding60.81M
Float53.89M
Short % of Float+5.05%

Source: Nexqual, June 10, 2026 at 03:42 UTC.

Leadership (INMD)

INMD is led by Moshe Mizrahy (age 72), Co-Founder, CEO & Director, per Nexqual as of June 10, 2026 at 03:42 UTC.

Co-Founder, CEO & DirectorMoshe Mizrahy (age 72)
Co-Founder, CTO & DirectorMichael Kreindel (age 57)
President of North AmericaMichael Dennison (age 44)
Chief Financial OfficerMoshik Itzkovich
Vice President of Sales of CanadaMatt Rodgers

Major Backers & Investors (INMD)

Notable institutional backers of INMD include Doma Perpetual Capital Management LLC, Acadian Asset Management. LLC, Renaissance Technologies, according to Nexqual as of June 10, 2026 at 03:42 UTC.

Active Investors

InvestorStake
Doma Perpetual Capital Management LLC4.84%
Acadian Asset Management. LLC4.09%
Renaissance Technologies4.08%
Menora Mivtachim Holdings Ltd.3.22%
Steel Partners Holdings, LP2.83%
Morgan Stanley2.09%
Millennium Management1.83%
Systematic Financial Management, L.P.1.82%

Index Funds (Passive)

FundStake
BlackRock5.22%

Source: Nexqual, June 10, 2026 at 03:42 UTC.

Peers & Related Stocks

SymbolNamePriceChange
PGNYProgyny, Inc.USD 25.83▼ 0.12%
DOCSDoximity, Inc.USD 20.45▼ 0.68%
APPSDigital Turbine, Inc.USD 9.85▲ 9.32%
BILLBILL Holdings, Inc.USD 34.09▼ 5.23%
PUBMPubMatic, Inc.USD 11.51▼ 0.26%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:42 UTC. This page is informational and not investment advice.